Background

The Foreign-Trade Zones Board has approved the establishment of subzone 76B at the MannKind Corporation facilities in Danbury, Conn., which are used for the production of inhalable insulin. Production under zone procedures at these facilities is currently under review.

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.